Health Care -
Health Care

QS-21

Product Description

Quillaja saponaria Molina is a South American tree native to Chile whose bark is rich in a complex mixture of triterpenic saponins. Quillaja-derived saponins such as Quil-A® are currently used as veterinary vaccine adjuvants. One specific fraction of the Quil-A saponin mixture, QS-21, is an extremely potent adjuvant with potential use in a broad variety of vaccines. It has been shown to enhance antibody- and cell-mediated immune response and has been investigated for human vaccine applications. It was originally isolated and named by Dr Charlotte Kensil in 1991 and among the components of triterpenoid quillaja saponins, QS-21 possesses an optimal balance of low toxicity and high immunostimulatory efficacy, and has already been used in one commercialised vaccine.

Order a sample Add to favourites
Chemical Group
  • Purified quillaja saponin
Market Application
  • Human Vaccines
Functions
  • Vaccine Adjuvant
Administration Route
  • Vaccine Adjuvant
Typical Properties
Physical form
  • -
Literature

Immunologic Adjuvant QS-21

Language: English | Type: Presentation | Size: 313.13kb

Login/Register

Vaccine Adjuvants

Bringing 80 years of expertise to you

Language: English | Type: Brochure | Size: 4266.5kb

Login/Register

QS-21

Quillaja saponaria Molina is a South American tree native to Chile whose bark is rich in a complex mixture of triterpenic saponins. Quillaja-derived saponins such as Quil-A® are currently used as veterinary vaccine adjuvants

Language: English | Type: Data Sheet | Size: 261.15kb

Login/Register

QS-21 Infographic

QS-21 is a purified saponin fraction from the bark of the South American tree Quillaja saponaria Molina

Language: English | Type: Flier | Size: 138.48kb

Login/Register

About cookies on this site
By continuing to use this website, you agree to the use of cookies. You can find out more details in our Privacy policy.